Storia in 3 fonti

Eli Lilly invests $40M in Absci for AI-designed injectable antibody ABS-201

Eli Lilly led a $100M equity round in Absci, investing $40M to advance ABS-201, the first AI-designed injectable antibody targeting hair loss and

Raccontata da

Confronto fonti

3 prospettive sulla stessa storia

AI · summaries

cryptobriefing.comStai leggendo1 mese fa

Eli Lilly led a $100M equity round in Absci, investing $40M to advance ABS-201, the first AI-designed injectable antibody targeting hair loss and

The GLP-1 maker’s latest AI investment targets drug discovery and the future of consumer medicine.